Avoid concomitant usage of tucatinib with CYP3A substrates, in which minimum focus changes might bring about serious or lifestyle-threatening toxicities. If unavoidable, decrease CYP3A substrate dose according to product or service labeling. lapatinib will boost the level or influence of diazepam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Keep https://francisa825quy3.mappywiki.com/user